Medium Chain Triglycerides (MCTs)
Overview
Medium chain triglycerides (MCTs) are partially man-made fats. The name refers to the way the carbon atoms are arranged in their chemical structure. MCTs are generally made by processing coconut and palm kernel oils in the laboratory. Usual dietary fats, by comparison, are long-chain triglycerides. People use MCTs as medicine.
Some people take MCTs by mouth along with usual medications for treating food absorption disorders including diarrhea, steatorrhea (fat indigestion), celiac disease, liver disease, and digestion problems due to partial surgical removal of the stomach (gastrectomy) or the intestine (short bowel syndrome).
MCTs are also taken by mouth for "milky urine" (chyluria) and a rare lung condition called chylothorax. Other uses include treatment of gallbladder disease, AIDS, cystic fibrosis, Alzheimer's disease, and seizures in children.
Athletes sometimes take MCTs by mouth for nutritional support during training, to increase exercise performance, for decreasing body fat and increasing lean muscle mass, and for weight loss.
MCTs are also sometimes taken by mouth to reduce levels of cholesterol and other fats in the blood called triglycerides. They might also be used for diabetes. In older people, MCTs are used to increase muscle mass and strength. They are also used for a rare disease called Waldmann disease.
MCTs are sometimes used as a source of fat in total parenteral nutrition (TPN). In TPN, all food is delivered intravenously (by IV). This type of feeding is necessary in people whose gastrointestinal (GI) tract is no longer working.
Intravenous MCTs are also given to prevent muscle breakdown in critically ill patients.
Classification
Is a Form of:
Man-made fats
Primary Functions:
Diarrhea, steatorrhea, celiac disease
Also Known As:
Acide Laurique, Capric Acid, Caproic Acid
How Does It Work?
MCTs are a fat source for patients who cannot tolerate other types of fats. Researchers also think that these fats produce chemicals in the body that might help fight Alzheimer's disease. These fats might also result in weight loss because the body uses them in a different way to other types of fats.
Uses
- Preventing muscle breakdown in critically ill patients, when given intravenously (by IV). MCTs can provide calories in critically ill patients, but don't seem to offer any advantages over normal dietary fats (long chain triglycerides).
- Certain types of seizures in children. Some research shows that taking MCTs by mouth can reduce some types of seizures such as akinetic, clonic, and petit mal.
- A rare disease called Waldmann disease. Following a low-fat, high-protein diet and supplementing with MCTs seems to reduce symptoms in patients with Waldmann disease.
Recommended Dosing
The following doses have been studied in scientific research:
ADULTS
BY IV:
- For preventing muscle breakdown in critically ill patients: As a fat source for people who receive all their food intravenously (by IV): a fat mixture containing 50% MCTs and 50% long chain triglycerides (usual dietary fats) is commonly used in total parenteral nutrition (TPN) formulas.
CHILDREN
BY MOUTH:
- For improving seizure control: MCT oil is used as 60% of the calories eaten.
Medium Chain Triglycerides (MCTs) Supplements Frequently Asked Questions
What are medium chain triglycerides good for?
Athletes sometimes take MCTs by mouth for nutritional support during training, to increase exercise performance, for decreasing body fat and increasing lean muscle mass, and for weight loss. MCTs are also sometimes taken by mouth to reduce levels of cholesterol and other fats in the blood called triglycerides.
What are medium chain triglycerides foods?
Here's a quick list of foods that contain MCTs, shown as a percentage of total fats:
- Coconut oil: 15%
- Palm kernel oil: 7.9%
- Cheese: 7.3%
- Butter: 6.8%
- Milk: 6.9%
- Yogurt: 6.6%
What is the highest quality MCT oil?
- Best Overall: Bulletproof Brain Octane Oil.
- Best Overall Runner-Up: Kiss My Keto MCT Oil Brain Fuel.
- Best Budget: Nature's Way Organic MCT Oil.
- Best Budget Runner-Up: Dr.
- Best Flavorless: Natural Force 100% Pure Coconut MCT Oil.
- Best Hexane-Free: Garden of Life Dr.
- Best Powder: Perfect Keto MCT Oil Powder Unflavored.
Is MCT oil good for pancreatitis?
Pancreatitis is an inflammatory condition, and antioxidants may help reduce inflammation. Lean meats can help people with pancreatitis meet their protein needs. For people with chronic pancreatitis, adding MCTs to their diet may improve nutrient absorption. People often consume MCTs in supplement form as MCT oil.
Is medium chain triglycerides bad for you?
But despite that saturated fat is known to raise cholesterol levels, linked with heart disease risk, proponents believe that some saturated fats in coconut oil (called medium-chain triglycerides) are less harmful and may actually raise levels of beneficial HDL cholesterol.
Is MCT oil bad for your liver?
High Doses Could Lead to Fat Buildup in the Liver
High doses of MCT oil may increase the amount of fat in your liver in the long term. One 12-week study in mice found that a diet in which 50% of the fats were MCTs increased liver fat.
Why does MCT oil make you poop?
MCT (medium-chain triglycerides) oil — Not only can it help with ketosis and fat burning, but it also aids in constipation due to rapid absorption.
Do avocados have MCT?
M.C.T. stands for “medium chain triglycerides,” (triglyceride = fat). Unlike short-chain and long-chain fatty acids (like those found in avocados and olive oil), certain types of medium-chain fatty acids – caproic acid (C6), caprylic acid (C8), and capric acid (C10) – don't need to be digested by your stomach.
Is MCT oil bad for your heart?
Summary MCT oil may reduce heart disease risk factors such as weight, cholesterol and inflammation. Adding it to your diet could help lower your risk of heart disease.
Does MCT Oil reduce belly fat?
The same study also discovered a lower rise in triglycerides and glucose with MCT oil, which may also influence the feeling of fullness. Additionally, taking MCT oil has been shown to significantly reduce body weight and waist circumference. Researchers even report that it could help prevent obesity.
Is MCT oil harmful?
MCTs are LIKELY SAFE for most people when taken by mouth or given intravenously (by IV). They can cause diarrhea, vomiting, irritability, nausea, stomach discomfort, intestinal gas, essential fatty acid deficiency, and other side effects. Taking MCTs with food might reduce some side effects.
Can MCT oil make you gain weight?
Taking MCT oil adds extra fats and calories to a person's diet. As such, excessive use of MCT oil may not be beneficial and could lead a person to gain weight. However, solid coconut oil, which is high in MCTs, can be used in cooking and may be used to replace olive oil or other cooking oils.
Does MCT oil put you in ketosis?
MCTs can be converted into ketones, which are produced from the breakdown of fat when carb intake is low. If you're following a ketogenic diet, which is very low in carbs yet high in fat, then taking MCT oil can help you stay in the fat-burning state known as ketosis.
How much MCT oil should I take daily?
Once your body adapts to the increase in MCT consumption, you can up your dosage daily, teaspoon by teaspoon, until you are having 1 to 4 tablespoons a day without any issues. The typical dose is one to two tablespoons per day.
What are the side effects of MCT oil?
Side Effects & Safety
MCTs are LIKELY SAFE for most people when taken by mouth or given intravenously (by IV). They can cause diarrhea, vomiting, irritability, nausea, stomach discomfort, intestinal gas, essential fatty acid deficiency, and other side effects. Taking MCTs with food might reduce some side effects.
Can I drink MCT oil straight?
One of the good things about MCT oil is that it has virtually no taste or smell. It can be consumed straight from the jar or mixed into food or drinks. Coconut and palm kernel oils are rich sources of medium-chain triglycerides, but MCT oil supplements contain much larger amounts.
Does MCT oil actually work?
While research is promising, there isn't enough data to show that MCT oil will lead to weight loss. MCT oil may help boost your strength if you're elderly and weak. There's also some evidence that MCT can raise the amount of energy used by your muscles.
Does MCT Oil Really Work?
MCT oil has been shown to support weight and fat loss. The same study also found better reductions in LDL or “bad” cholesterol when the MCT oil mixture was added to their diet ( 34 ). Moreover, MCT oil can also increase the production of heart-protective HDL or “good” cholesterol ( 35 ).
Is MCT oil a laxative?
MCT (medium-chain triglycerides) oil has a natural laxative effect. Switch out your coconut oil for MCT oil to help with constipation. Be careful to gradually incorporate MCT oil into your diet, because too much of MCT too quickly may cause stomach cramps, etc.
Does Ghee have MCT?
Ghee contains many fat-soluble vitamins such as vitamins A, E, and K, and it is also high in saturated fat. Well, it mainly stems from the concept surrounding medium-chain triglycerides (MCTs), a type of fat that is found in coconut oil and ghee, which makes complete sense as to why ghee is receiving so much attention.
Is MCT oil bad for cholesterol?
MCT oil has been shown to support weight and fat loss. The same study also found better reductions in LDL or “bad” cholesterol when the MCT oil mixture was added to their diet ( 34 ). Moreover, MCT oil can also increase the production of heart-protective HDL or “good” cholesterol ( 35 ).
How long does MCT oil last in your body?
One study found that an MCT-rich diet caused greater fat burning and fat loss than a diet higher in LCTs. However, these effects may disappear after 2–3 weeks once the body has adapted.
Is MCT oil better than coconut oil?
MCT oil is better for ketone production and weight loss
Compared with coconut oil, MCT oil is better for ketone production and maintaining ketosis. MCT oil has much larger proportions of the more ketogenic MCTs than coconut oil, which contains the greatest concentration of lauric acid, the least ketogenic MCT.
Clinical Studies
- ^Babayan V. Medium chain length fatty acid esters and their medical and nutritional applications. J Am Oil Chem Soc. (1981)
- ^Sigalet DL, Martin G. Lymphatic absorption of glucose and fatty acids as determined by direct measurement. J Pediatr Surg. (1999)
- ^Sigalet DL, Winkelaar GB, Smith LJ. Determination of the route of medium-chain and long-chain fatty acid absorption by direct measurement in the rat. JPEN J Parenter Enteral Nutr. (1997)
- ^USDA Food Composition Database Nutrient list for C6:0, C8:0, and C10:0.
- ^ ab c Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr. (1982)
- ^Ghosh S, Bhattacharyya DK. Medium-chain fatty acid-rich glycerides by chemical and lipase-catalyzed polyester-monoester interchange reaction. J Amer Oil Chem Soc. (1997)
- ^Mu H, Porsgaard T. The metabolism of structured triacylglycerols. Prog Lipid Res. (2005)
- ^Mansbach CM 2nd, Gorelick F. Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicrons. Am J Physiol Gastrointest Liver Physiol. (2007)
- ^McLaughlin J, et al. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology. (1999)
- ^Symersky T, et al. The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clin Physiol Funct Imaging. (2002)
- ^ ab You YQ, et al. Effects of medium-chain triglycerides, long-chain triglycerides, or 2-monododecanoin on fatty acid composition in the portal vein, intestinal lymph, and systemic circulation in rats. JPEN J Parenter Enteral Nutr. (2008)
- ^Iber FL. Relative rates of metabolism MCT, LCT and ethanol in man. Z Ernahrungswiss Suppl. (1974)
- ^Borel P, et al. Chylomicron beta-carotene and retinyl palmitate responses are dramatically diminished when men ingest beta-carotene with medium-chain rather than long-chain triglycerides. J Nutr. (1998)
- ^ ab Swift LL, et al. Medium-chain fatty acids: evidence for incorporation into chylomicron triglycerides in humans. Am J Clin Nutr. (1990)
- ^Rubio-Gozalbo ME, et al. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects. Mol Aspects Med. (2004)
- ^Bach A, Phan T, Metais P. Effect of the fatty acid composition of ingested fats on rat liver intermediary metabolism. Horm Metab Res. (1976)
- ^Bach A. Oxaloacetate deficiency in MCT-induced ketogenesis. Arch Int Physiol Biochim. (1978)
- ^McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem. (1980)
- ^Yeh YY, Zee P. Relation of ketosis to metabolic changes induced by acute medium-chain triglyceride feeding in rats. J Nutr. (1976)
- ^Bach A, et al. Ketogenic response to medium-chain triglyceride load in the rat. J Nutr. (1977)
- ^McGarry JD, Foster DW. The regulation of ketogenesis from octanoic acid. The role of the tricarboxylic acid cycle and fatty acid synthesis. J Biol Chem. (1971)
- ^ ab Vandenberghe C, et al. Tricaprylin alone increases plasma ketone response more than coconut oil or other medium chain triglycerides: an acute crossover study in healthy adults. Curr Dev Nutr. (2017)
- ^Adkison KD, Shen DD. Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter. J Pharmacol Exp Ther. (1996)
- ^ ab Chang P, et al. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain. (2016)
- ^ ab Van Wymelbeke V, Louis-Sylvestre J, Fantino M. Substrate oxidation and control of food intake in men after a fat-substitute meal compared with meals supplemented with an isoenergetic load of carbohydrate, long-chain triacylglycerols, or medium-chain triacylglycerols. Am J Clin Nutr. (2001)
- ^ ab Rolls BJ, et al. Food intake in dieters and nondieters after a liquid meal containing medium-chain triglycerides. Am J Clin Nutr. (1988)
- ^St-Onge MP, et al. Impact of medium and long chain triglycerides consumption on appetite and food intake in overweight men. Eur J Clin Nutr. (2014)
- ^ ab c Van Wymelbeke V, et al. Influence of medium-chain and long-chain triacylglycerols on the control of food intake in men. Am J Clin Nutr. (1998)
- ^Stubbs RJ, Harbron CG. Covert manipulation of the ratio of medium- to long-chain triglycerides in isoenergetically dense diets: effect on food intake in ad libitum feeding men. Int J Obes Relat Metab Disord. (1996)
- ^ ab Krotkiewski M. Value of VLCD supplementation with medium chain triglycerides. Int J Obes Relat Metab Disord. (2001)
- ^ ab c d Han JR, et al. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism. (2007)
- ^ ab Martin K, et al. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev. (2016)
- ^Lima PA, Sampaio LP, Damasceno NR. Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy. Clinics (Sao Paulo). (2014)
- ^Masino SA, Rho JM. Mechanisms of Ketogenic Diet Action.
- ^Groleau V, et al. Long-term impact of the ketogenic diet on growth and resting energy expenditure in children with intractable epilepsy. Dev Med Child Neurol. (2014)
- ^Bergqvist AG, et al. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr. (2008)
- ^ ab Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology. (1971)
- ^Huttenlocher PR. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res. (1976)
- ^Trauner DA. Medium-chain triglyceride (MCT) diet in intractable seizure disorders. Neurology. (1985)
- ^Sills MA, et al. The medium chain triglyceride diet and intractable epilepsy. Arch Dis Child. (1986)
- ^ ab Schwartz RH, et al. Ketogenic diets in the treatment of epilepsy: short-term clinical effects. Dev Med Child Neurol. (1989)
- ^ ab Schwartz RM, Boyes S, Aynsley-Green A. Metabolic effects of three ketogenic diets in the treatment of severe epilepsy. Dev Med Child Neurol. (1989)
- ^Liu YM. Medium-chain triglyceride (MCT) ketogenic therapy. Epilepsia. (2008)
- ^Liu YM, Wang HS. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed J. (2013)
- ^Neal EG, et al. Growth of children on classical and medium-chain triglyceride ketogenic diets. Pediatrics. (2008)
- ^ ab c d Neal EG, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. (2009)
- ^ ab Azzam R, Azar NJ. Marked Seizure Reduction after MCT Supplementation. Case Rep Neurol Med. (2013)
- ^ ab c Reger MA, et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging. (2004)
- ^ ab c Henderson ST, et al. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond). (2009)
- ^ ab Rebello CJ, et al. Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: A randomized controlled trial. BBA Clin. (2015)
- ^Cunnane SC, et al. Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's Disease. Front Mol Neurosci. (2016)
- ^ ab Tsuji H, et al. Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J Nutr. (2001)
- ^Tsai YH, et al. Mechanisms mediating lipoprotein responses to diets with medium-chain triglyceride and lauric acid. Lipids. (1999)
- ^ ab c d Temme EH, Mensink RP, Hornstra G. Effects of medium chain fatty acids (MCFA), myristic acid, and oleic acid on serum lipoproteins in healthy subjects. J Lipid Res. (1997)
- ^ ab Swift LL, et al. Plasma lipids and lipoproteins during 6 d of maintenance feeding with long-chain, medium-chain, and mixed-chain triglycerides. Am J Clin Nutr. (1992)
- ^ ab Hill JO, et al. Changes in blood lipids during six days of overfeeding with medium or long chain triglycerides. J Lipid Res. (1990)
- ^ ab HASHIM SA, ARTEAGA A, VAN ITALLIE TB. Effect of a saturated medium-chain triglyceride on serum-lipids in man. Lancet. (1960)
- ^ ab St-Onge MP, et al. Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J Am Coll Nutr. (2008)
- ^Tremblay AJ, et al. Dietary medium-chain triglyceride supplementation has no effect on apolipoprotein B-48 and apolipoprotein B-100 kinetics in insulin-resistant men. Am J Clin Nutr. (2014)
- ^van Schalkwijk DB, et al. Dietary medium chain fatty acid supplementation leads to reduced VLDL lipolysis and uptake rates in comparison to linoleic acid supplementation. PLoS One. (2014)
- ^Turkenkopf IJ, Maggio CA, Greenwood MR. Effect of high fat weanling diets containing either medium-chain triglycerides or long-chain triglycerides on the development of obesity in the Zucker rat. J Nutr. (1982)
- ^ ab c Kasai M, et al. Effect of dietary medium- and long-chain triacylglycerols (MLCT) on accumulation of body fat in healthy humans. Asia Pac J Clin Nutr. (2003)
- ^Xue C, et al. Consumption of medium- and long-chain triacylglycerols decreases body fat and blood triglyceride in Chinese hypertriglyceridemic subjects. Eur J Clin Nutr. (2009)
- ^Zhang YH, et al. Medium- and long-chain fatty acid triacylglycerol reduce body fat and serum triglyceride in overweight and hypertriglyceridemic subjects. Zhonghua Yu Fang Yi Xue Za Zhi. (2009)
- ^Liu Y, et al. A good response to oil with medium- and long-chain fatty acids in body fat and blood lipid profiles of male hypertriglyceridemic subjects. Asia Pac J Clin Nutr. (2009)
- ^Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation. (1997)
- ^Zhang Y, et al. Medium- and long-chain triacylglycerols reduce body fat and blood triacylglycerols in hypertriacylglycerolemic, overweight but not obese, Chinese individuals. Lipids. (2010)
- ^Asakura L, et al. Dietary medium-chain triacylglycerol prevents the postprandial rise of plasma triacylglycerols but induces hypercholesterolemia in primary hypertriglyceridemic subjects. Am J Clin Nutr. (2000)
- ^Cater NB, Heller HJ, Denke MA. Comparison of the effects of medium-chain triacylglycerols, palm oil, and high oleic acid sunflower oil on plasma triacylglycerol fatty acids and lipid and lipoprotein concentrations in humans. Am J Clin Nutr. (1997)
- ^UZAWA H, et al. HYPERGLYCERIDEMIA RESULTING FROM INTAKE OF MEDIUM CHAIN TRIGLYCERIDES. Am J Clin Nutr. (1964)
- ^ ab Eckel RH, et al. Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects. Diabetes. (1992)
- ^Airhart S, et al. A Diet Rich in Medium-Chain Fatty Acids Improves Systolic Function and Alters the Lipidomic Profile in Patients With Type 2 Diabetes: A Pilot Study. J Clin Endocrinol Metab. (2016)
- ^Hayes KC. Medium-chain triacylglycerols may not raise cholesterol. Am J Clin Nutr. (2000)
- ^Pi-Sunyer FX, Hashim SA, Van Itallie TB. Insulin and ketone responses to ingestion of medium and long-chain triglycerides in man. Diabetes. (1969)
- ^Tamir I, et al. Effects of a single oral load of medium-chain triglyceride on serum lipid and insulin levels in man. J Lipid Res. (1968)
- ^Yost TJ, et al. Dietary substitution of medium chain triglycerides in subjects with non-insulin-dependent diabetes mellitus in an ambulatory setting: impact on glycemic control and insulin-mediated glucose metabolism. J Am Coll Nutr. (1994)
- ^Souza PF, Williamson DH. Effects of feeding medium-chain triacylglycerols on maternal lipid metabolism and pup growth in lactating rats. Br J Nutr. (1993)
- ^Lieber CS, et al. Difference in hepatic metabolism of long- and medium-chain fatty acids: the role of fatty acid chain length in the production of the alcoholic fatty liver. J Clin Invest. (1967)
- ^Johnson RC, et al. Medium-chain-triglyceride lipid emulsion: metabolism and tissue distribution. Am J Clin Nutr. (1990)
- ^Watkins JB, et al. Diagnosis and differentiation of fat malabsorption in children using 13C-labeled lipids: trioctanoin, triolein, and palmitic acid breath tests. Gastroenterology. (1982)
- ^Metges CC, Wolfram G. Medium- and long-chain triglycerides labeled with 13C: a comparison of oxidation after oral or parenteral administration in humans. J Nutr. (1991)
- ^Schoeller DA, et al. 13C abundances of nutrients and the effect of variations in 13C isotopic abundances of test meals formulated for 13CO2 breath tests. Am J Clin Nutr. (1980)
- ^ ab c Papamandjaris AA, et al. Endogenous fat oxidation during medium chain versus long chain triglyceride feeding in healthy women. Int J Obes Relat Metab Disord. (2000)
- ^ ab Binnert C, et al. Influence of human obesity on the metabolic fate of dietary long- and medium-chain triacylglycerols. Am J Clin Nutr. (1998)
- ^Carnitine Palmitoyltransferase 1A Deficiency.
- ^Geliebter A, et al. Overfeeding with medium-chain triglyceride diet results in diminished deposition of fat. Am J Clin Nutr. (1983)
- ^Dulloo AG, et al. Differential effects of high-fat diets varying in fatty acid composition on the efficiency of lean and fat tissue deposition during weight recovery after low food intake. Metabolism. (1995)
- ^Crozier G, et al. Metabolic effects induced by long-term feeding of medium-chain triglycerides in the rat. Metabolism. (1987)
- ^Lavau MM, Hashim SA. Effect of medium chain triglyceride on lipogenesis and body fat in the rat. J Nutr. (1978)
- ^Papamandjaris AA, White MD, Jones PJ. Components of total energy expenditure in healthy young women are not affected after 14 days of feeding with medium-versus long-chain triglycerides. Obes Res. (1999)
- ^Roynette CE, et al. Structured medium and long chain triglycerides show short-term increases in fat oxidation, but no changes in adiposity in men. Nutr Metab Cardiovasc Dis. (2008)
- ^Assunção ML, et al. Effects of dietary coconut oil on the biochemical and anthropometric profiles of women presenting abdominal obesity. Lipids. (2009)
- ^Clegg ME. Medium-chain triglycerides are advantageous in promoting weight loss although not beneficial to exercise performance. Int J Food Sci Nutr. (2010)
- ^Does medium chain triglyceride play an ergogenic role in endurance exercise performance?.
- ^Hawley JA, Brouns F, Jeukendrup A. Strategies to enhance fat utilisation during exercise. Sports Med. (1998)
- ^Horowitz JF, et al. Preexercise medium-chain triglyceride ingestion does not alter muscle glycogen use during exercise. J Appl Physiol. (2000)
- ^Misell LM, et al. Chronic medium-chain triacylglycerol consumption and endurance performance in trained runners. J Sports Med Phys Fitness. (2001)
- ^Goedecke JH, et al. The effects of medium-chain triacylglycerol and carbohydrate ingestion on ultra-endurance exercise performance. Int J Sport Nutr Exerc Metab. (2005)
- ^Angus DJ, et al. Effect of carbohydrate or carbohydrate plus medium-chain triglyceride ingestion on cycling time trial performance. J Appl Physiol. (2000)
- ^Kehayoglou K, et al. The effect of medium-chain triglyceride on 47 calcium absorption in patients with primary biliary cirrhosis. Gut. (1973)
- ^Harrison JE, et al. Effect of medium chain triglyceride on fecal calcium losses in pancreatic insufficiency. Clin Biochem. (1973)
- ^Tandon RK, Rodgers JB Jr, Balint JA. The effects of medium-chain triglycerides in the short bowel syndrome. Increased glucose and water transport. Am J Dig Dis. (1972)
- ^ ab c Traul KA, et al. Review of the toxicologic properties of medium-chain triglycerides. Food Chem Toxicol. (2000)
- ^Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. (2016)
- White MD, Papamandjaris AA, Jones PJ. Enhanced postprandial energy expenditure with medium-chain fatty acid feeding is attenuated after 14 d in premenopausal women. Am J Clin Nutr. (1999)